NCT06417177View on ClinicalTrials.gov

Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
AgingMenopauseHypoxiaVasodilation
Interventions
DRUG

Placebo

Participants will receive a placebo in pill form.

DRUG

Propranolol

Participants will receive oral propranolol (1 mg/kg).

DRUG

Gemtesa

Participants will receive oral gemtesa (75 mg).

Trial Locations (1)

65211

RECRUITING

University of Missouri-Columbia, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER